Results 191 to 200 of about 446,222 (404)
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
American Journal of Gastroenterology, 1998 Kenneth K Wang, R. Sampliner
semanticscholar +1 more source
Annals of Gastroenterological Surgery, EarlyView.ROC analyses of APRI score, EOB‐MRI, and a combination of EOB‐MRI and APRI score for blue liver. ABSTRACT Aim Sinusoidal obstruction syndrome (SOS), also known as “blue liver (BL),” is a common hepatic injury following oxaliplatin‐based chemotherapy in patients with colorectal liver metastases (CRLM).
Tomonari Shimagaki +7 more
wiley +1 more source
The Rare Upper Thoracic and Cervical Esophageal GIST Resected Through Thoracoscopic Esophageal Mobilization and a Cervical Approach: A Case Report. [PDF]
Cancer Rep (Hoboken)Ishii K +13 more
europepmc +1 more source
Screening for Barrett’s esophagus: Balancing clinical value and cost-effectiveness [PDF]
, 2019 Gyawali, C Prakash, Patel, Amit
core +1 more source
Primary malignant melanoma of the esophagus [PDF]
, 1981 Mark E. Ludwig +2 more
openalex +1 more source
Incidence of adenocarcinoma among patients with Barrett's esophagus.
New England Journal of Medicine, 2011 F. hvid-Jensen +4 more
semanticscholar +1 more source
Annals of Gastroenterological Surgery, EarlyView.ABSTRACT Aim Serum tumor markers are helpful for diagnosis, monitoring treatment outcomes, and prognosis. However, their clinical utility for esophageal squamous cell carcinoma (ESCC) and gastric cancer (GC) remains unclear. This study aimed to comprehensively evaluate recent studies on serum tumor markers in ESCC and GC.
Yasunori Matsumoto +2 more
wiley +1 more source
Atypical presentation of esophageal Dieulafoy: diagnostic and therapeutic challenges in end stage achalasia. [PDF]
J Surg Case RepFiesal Y +4 more
europepmc +1 more source